U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2730127301Office-based Vision Therapy for Improving Reading and Attention in Children With Convergence InsufficiencyRecruitingNo Results AvailableConvergence InsufficiencyProcedure: Office-based vergence/accommodative therapyhttps://ClinicalTrials.gov/show/NCT02207517
2730227302Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate CancerRecruitingNo Results AvailableCastration-resistant Prostate CancerDrug: Crizotinib|Drug: Enzalutamidehttps://ClinicalTrials.gov/show/NCT02207504
2730327303Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionCompletedNo Results AvailableOcular Hypertension|Open-angle GlaucomaDrug: Timolol maleate Ophthalmic Solution, 0.5%|Drug: AR-13324 Ophthalmic Solution, 0.02%https://ClinicalTrials.gov/show/NCT02207491
2730427304ENB-GS-TBLB for the Diagnosis of PPLsRecruitingNo Results AvailableLung CancerProcedure: ENB|Procedure: GS-TBLB-X-rayhttps://ClinicalTrials.gov/show/NCT02207478
2730527305A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic CancerRecruitingNo Results AvailableLocally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy|Borderline Resectable Pancreatic Cancer Treated With ChemoradiotherapyRadiation: Radiotherapy|Drug: Gemcitabine 1000 mg|Drug: nab-paclitaxel 125 mghttps://ClinicalTrials.gov/show/NCT02207465
2730627306Helium-3 MRI Imaging Study in COPDCompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDevice: He-3 MRI|Drug: Salbutamol|Drug: Ipratropium|Device: MRIhttps://ClinicalTrials.gov/show/NCT02207452
2730727307A Phase II Trial of a Protease Inhibitor, Nelfinavir (NFV), Given With Definitive, Concurrent Chemoradiotherapy (CTRT) in Patients With Locally-Advanced, Human Papilloma Virus (HPV) Negative, Squamous Cell Carcinoma LarynxRecruitingNo Results AvailableStage III, IVa, or IVb Squamous Cell Carcinoma of the Larynx, With ECOG Performance Status 0-2Drug: Nelfinavir (Viracept®) 1250 mghttps://ClinicalTrials.gov/show/NCT02207439
2730827308Pharmacokinetic and Pharmacoscintigraphic Comparison of TobrAir® 6.0 With TOBI® and TOBI® Podhaler™Active, not recruitingNo Results AvailableHealthyDrug: Tobramycinhttps://ClinicalTrials.gov/show/NCT02207426
2730927309A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and ChildrenCompletedNo Results AvailableInfluenzaBiological: FLU-D-QIV IP|Biological: FLU-D-QIV LPhttps://ClinicalTrials.gov/show/NCT02207413
2731027310A Six Month Clinical Study Based in the US to Evaluate the Efficacy and Tolerability of Sodium Bicarbonate Toothpaste and Its Effect on Opportunistic or Resistant OrganismsCompletedNo Results AvailableOral HygieneDrug: Sodium bicarbonate plus sodium fluoride|Drug: Sodium fluoridehttps://ClinicalTrials.gov/show/NCT02207400
2731127311Ambulosono Rasagiline Musical Walking StudyRecruitingNo Results AvailableParkinson's DiseaseDrug: Azilect|Behavioral: Exercise|Other: Musichttps://ClinicalTrials.gov/show/NCT02207387
2731227312A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 DiabetesActive, not recruitingNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: semaglutide|Drug: Other OADhttps://ClinicalTrials.gov/show/NCT02207374
2731327313Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast CancerRecruitingNo Results AvailableMetastatic Breast CancerDrug: Paclitaxel, Carboplatin|Drug: Paclitaxel, Epirubicinhttps://ClinicalTrials.gov/show/NCT02207361
2731427314Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectorsCompletedNo Results AvailableMetabolism and Nutrition Disorder|ObesityDrug: liraglutidehttps://ClinicalTrials.gov/show/NCT02207348
2731527315Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast CancerRecruitingNo Results AvailableMetastatic Breast CancerDrug: Gemcitabine,Capecitabine|Drug: Gemcitabine, Carboplatinhttps://ClinicalTrials.gov/show/NCT02207335
2731627316Supportive Care Intervention In Patients Hospitalized For Hematopoietic Stem Cell Transplantation (Shield)RecruitingNo Results AvailableComplication of TransplantOther: transplant with early palliative carehttps://ClinicalTrials.gov/show/NCT02207322
2731727317Pazopanib Maintenance Phase IIRecruitingNo Results AvailableSarcomaDrug: Pazopanib|Drug: Placebo (for Pazopanib)https://ClinicalTrials.gov/show/NCT02207309
2731827318Operative Hemodynamic Optimization Using the Plethysmographic Variability Index During Orthopedic SurgeryRecruitingNo Results AvailableHip Arthroplasty|Knee Arthroplasty|General AnesthesiaDevice: Plethysmographic variability indexhttps://ClinicalTrials.gov/show/NCT02207296
2731927319PDE5 Inhibition to Alleviate Functional Muscle Ischemia in Becker Muscular DystrophyActive, not recruitingNo Results AvailableBecker Muscular DystrophyDrug: Tadalafil|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02207283
2732027320Study Of Costs Realized After Percutaneous Coronary intervenTion Employing Same Day DischargeTerminatedNo Results AvailableCoronary Artery DiseaseProcedure: Same day dischargehttps://ClinicalTrials.gov/show/NCT02207270
2732127321Study of PER977 Administered to Subjects With Steady State Edoxaban Dosing and Re-anticoagulation With EdoxabanRecruitingNo Results AvailableHealthy VolunteersDrug: PER977|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02207257
2732227322A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and RetreatmentRecruitingNo Results AvailablePsoriasisDrug: Guselkumab 100 mg|Drug: Placebo for guselkumab|Drug: Adalimumab|Drug: Placebo for adalimumabhttps://ClinicalTrials.gov/show/NCT02207244
2732327323A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type PsoriasisActive, not recruitingNo Results AvailablePsoriasisDrug: Guselkumab 100 mg|Drug: Placebo for guselkumab|Drug: Adalimumab|Drug: Placebo for adalimumabhttps://ClinicalTrials.gov/show/NCT02207231
2732427324To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in JapanRecruitingNo Results AvailableCongenital Bleeding Disorder|Haemophilia ADrug: turoctocog alfahttps://ClinicalTrials.gov/show/NCT02207218
2732527325Variability in the Measurement of WBCT Between Blood Drawn From Indwelling Catheters and Direct VenipunctureCompletedNo Results AvailableHealthyDrug: Blood drawn from indwelling catheters versus direct venipuncturehttps://ClinicalTrials.gov/show/NCT02207205
2732627326Postural Changes in Lung Volumes in ObesityCompletedNo Results AvailableObesityOther: Postural change in lung volumes: sitting to Supinehttps://ClinicalTrials.gov/show/NCT02207192
2732727327Breast Cancer Margin Delineation Using Polarization Subtraction Imaging TechnologyRecruitingNo Results AvailableBreast CancerDevice: LumaScan Image Guided Surgeryhttps://ClinicalTrials.gov/show/NCT02207179
2732827328Identify Possible Errors on Home Use Blood Pressure Monitors by Usability ReasoningCompletedNo Results AvailableHypertensionhttps://ClinicalTrials.gov/show/NCT02207166
2732927329Risk Assessment by Cardiovascular Biomarkers in Chronic Dialysis PatientsNot yet recruitingNo Results AvailableEndstage Renal Diseasehttps://ClinicalTrials.gov/show/NCT02207153
2733027330Effect of Multi-species Probiotic HOWARU® Restore, on Gut Microbiota of ElderlyRecruitingNo Results AvailableElderly|Probiotics|Clostridium Difficile|Gut Microbiota|Fecal MetabolomeDietary Supplement: HOWARU Restorehttps://ClinicalTrials.gov/show/NCT02207140

* Görseller ve İçerik tekif hakkına sahip olabilir